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ABSTRACT
Pseudomonas aeruginosa is an extremely wide spread microorganism linked to nosocomial
illnesses. Effective inspection of variations in antimicrobial resistance patterns of P.
aeruginosa is vital for selecting suitable antimicrobial drugs for pragmatic treatment. The
current research has been performed for assessing antimicrobial sensitivity profile of P.
aeruginosa isolated as of a variety of medical specimens collected from critical and noncritical admitted patients of Nishtar Hospital, Multan. The isolates were detected utilizing
standard lab practices, as well as the sensitivity was examined employing Kirby-Bauer disk
diffusion method corresponding to Clinical and Laboratory Standard Institute (CLSI)
recommendations 2019. Out of 373 samples, 110 (29.49 %) P. aeruginosa isolates were from
admitted patients in different wards. 82 (74.5 %) came from non-critical units along with 28
(25.4 %) belonged to critical units. Prevalence of P. aeruginosafrom the non-critical units
was detected from surgical ward 35 (42.6 %) followed by medical ward 25 (30.48 %),
gynecology 15 (18.29 %) and orthopedics 7 (8.5 %). The highest prevalence of P. aeruginosa
among critical areas were from Medicine Intensive Care Unit 14 (50 %) followed by Surgery
Intensive Care Unit 9 (32.14 %) and Respiratory Intensive Care Unit 5 (17.85 %). All were
observed as multidrug-resistant against different antibiotics. The current research facilitates
estimating the occurrence of MDR strains in intensive care units. Therefore, routine
investigation of antibiotic sensitivity patterns is crucial for lowering the healthcare-linked
infection levels as well as antimicrobial resistance.
Keywords: Pseudomonas aeruginosa, hospital acquired infections, antimicrobial resistance,
nosocomial infection, multidrug resistance.
INTRODUCTION
Antibiotic resistance is the main
apprehension of current medication.
Nosocomial infections are caused by the
emergence of resistant strains which
contributes to the morbidity along with
death of patients being hospitalized.
Pseudomonas aeruginosa is the next
greatest recurrent source of pneumonia,
the fourth most frequent cause of urinary
tract infections (UTI), and the sixth
common cause of bacteremia in intensive

care units (ICUs) due to the ubiquitous and
versatile opportunistic organism (Bekele et
al., 2015; Saeed et al., 2018). The
evolutionary antimicrobial resistance
tactics of bacteria have developed using a
wide variety of antibiotics resulting in the
emergence of resistance. Due to the
frightening increase of drug resistance, the
effectiveness of many antibiotics to treat
infections has become moderately
restricted. Thus, the threat from drugresistant strains is accumulating and
increasing day by day. Multidrug-resistant
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(MDR) P. aeruginosais considered as a
pervasive increase in clinical dilemma,
which is expected to be an alarming threat
to public health around the world. It has an
important role in the increased rate of
mortality and morbidity along with
healthcare costs (Bayani et al., 2013).
MDR P. aeruginosaisolates are known to
be resistant from three or more antibiotics
of the subsequent classes of antibiotics:
carbapenems, penicillins, cephalosporins,
monobactams,
aminoglycosides,
and
fluoroquinolones (Dash et al., 2014). MDR
strains of P. aeruginosaarbitrated different
mechanisms including bacterial efflux
pumps, altered target sites, loss of
membrane
proteins
and
enzyme
production or inhibition, etc (Odisha,
2012).
Nosocomial P. aeruginosaisolates
demonstrate high level of drug resistance.
ICUs of most hospitals cover maximum
number of critically ill patients from all the
wards. Among these patients nosocomial
infections
transmission
rate
is
approximately 20 % (Mythri and
Kashinath, 2014). Patients admitted in ICU
are further prone to Hospital-acquired
infections (HAIs) by P. aeruginosain
contrast to patients staying in non-critical
units (Bayani et al., 2013). The preference
of empiric administration in ICUs is
extremely complex. It is necessity to strike
a equilibrium between narrow spectrum as
well as broad spectrum antibiotics (Harris
et al., 2016). In critical units, MDR P.
aeruginosais
limiting
the
existing
therapeutic choices for bacterial infections
(Qadeer et al., 2016).
It is the need of hour to recognize
and respond the problem of evaluation of
the P. aeruginosasensitivity pattern against
regularly approved antimicrobial agents. It
would guide the physicians for the
justified use of currently available
antibacterial management choice. Thus,
the goal of the research was to assess
frequency along with antibiotic-resistance
profile of P. aeruginosaof hospitalized

patients from critical and non-critical units
at tertiary care hospital, Multan.
MATERIALS AND METHODS
Ethical Consideration
The investigation was carried out
after authorization from the Ethical
Committee of Nishtar Hospital Multan.
Study Duration
A cross-sectional investigation was
carried out in Nishtar Hospital, Multan in
the duration of January 2019 to August
2019.
Sample Size and Sample Collection
During this period of study, a total
of 373 samples of blood, pus, and urine
(from catheterized and non-catheterized)
were collected from critical and noncritical units of the hospital. Critical units
include the surgery intensive care unit
(SICU), respiratory intensive care unit
(RICU) as well as the medical intensive
care unit (MICU), and Non-critical units
include gynecology, general medicine,
respiratory medicine, surgery, and
orthopedic departments.
Isolation and Detection of P. aeruginosa
There were 110 P. aeruginosa
isolates found in total via a variety of
clinical specimens as of non-critical as
well as critical units at Nishtar Hospital
Multan. Gram staining followed by
various biochemical tests were performed
as per standard protocols (Colle et al.,
2007) for the identification of P.
aeruginosa.
Antimicrobial sensitivity Analysis
The disc diffusion method of
Kirby–Bauer was used to perform
antibiotic
sensitivity
evaluation.
Antimicrobial sensitivity testing was
77
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carried out via Muller Hinton Agar
(Hudzicki, 2009). Profiles of antimicrobial
susceptibility were obtained by following
antibiotics: piperacillin (100 mcg),
ceftazidime (30 mcg), ciprofloxacin (5
mcg), levofloxacin (5 mcg), aztreonam (30
mcg), gentamicin (10 mcg), imipenem (10
mcg) andmeropenem (10 mcg). The results
were noted in accordance with the Clinical
and Laboratory Standards Institute's
guidelines (CLSI protocols) (Balouiriet al.,
2016).

RESULTS
Distribution of P. aeruginosa
A total of 373 samples of blood,
pus, and urine (from catheterized & noncatheterized)
were
analyzed
from
hospitalized patients at Nishtar Hospital
Multan. Out of 373 samples, 110 (29.49
%) samples were positive for P.
aeruginosa.
The
isolates
of
P.
aeruginosawere categorized according to
the wards from which samples were
obtained; about 82 (75 %) isolates were
from non-critical areas and 28 (25 %) P.
aeruginosa strains were isolated via
critical areas of the hospital as represented
in Table 1.

Statistical Assessment
MS Excel was used to clean all
categorical data and statistical analysis was
done by XL-stat software 2010. All tests
were completed to explore the antibiotic
resistance of P. aeruginosa.
Table 1: Distribution of P. aeruginosa (N= 110)

Specimen

Non-Critical Sectors
No. of
% Age of
P.aeruginosaisolates P. aeruginosa
isolates

Critical Sectors
No. of
% Age of
P.
P. aeruginosa
aeruginosaisolates isolates

Pus
Urine
(Catheterized)

33
11

30 %
10 %

10
5

9.0 %
4.5 %

16.4 %

5

4.5 %

18.2 %
75 %

7
28

7.3 %
25 %

(Non
– 18
Catheterized)
Blood
20
Total
82

Table 2: Distribution of P. aeruginosabased on non-critical areas.
Non–Critical
Sectors
N = 82

Specimens
N (%)

Total
N (%)

Pus
(Catheterized)
Surgery
Medicine
Gynecology
Orthopedics

18 (21.9 %)
5 (6.09 %)
5 (6.09 %)
5 (6.09 %)

5 (6.09 %)
3 (3.65 %)
3 (3.65 %)
--

Urine
(Non-Catheterized)
7 (8.53 %)
7 (8.53 %)
4 (4.87 %)
--

Blood
5 (6.09 %)
10 (12.19 %)
3 (3.65 %)
2 (2.43 %)

35 (42.6 %)
25(30.48 %)
15(18.29 %)
7 (8.5 %)
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Table 3: Distribution of P. aeruginosa based on Critical areas
Critical Sectors
N = 28

S-ICU
M-ICU
R-ICU

Specimens
N (%)

Total
N (%)

Pus

Urine
(Catheterized)

Blood

4 (14.2 %)
3 (10.7 %)
3 (10.7 %)

3 (10.7 %)
7 (25 %)
-

2 (7.14 %)
4 (14.2 %)
2 (7.14 %)

Distribution of P. aeruginosaamong NonCritical and Critical areas
Among non-critical areas 82(74.5
%), isolation rate of P. aeruginosawas
found high in surgery ward 35(42.6 %)
followed by medicine 25(30.48 %),
gynecology 15(18.29 %), and orthopedics
7(8.5 %). The elevated incidence of P.
aeruginosawas found in pus specimens
18(21.9 %) from the surgery ward in noncritical areas as shown in Table 2. Out of
28(25 %) isolates of critical sectors, the
highest isolation of P. aeruginosawas
observed from medicine intensive care unit
(M-ICU) 14(50 %) followed by surgery
intensive care unit (S-ICU) 9(32.14 %) and
respiratory intensive care unit (R-ICU)
5(17.85 %).P. aeruginosaexhibited high
incidence in urine specimens from MICU
7(25 %) in critical areas as represented in
Table 3.

9 (32.14 %)
14 (50 %)
5 (17.85 %)

Antibiotic Susceptibility
The antibiotic sensitivity profile of
P. aeruginosaisolates was determined
through the Kirby-Bauer disk-diffusion
method (Hudzicki 2009). Eight antibiotic
discs
piperacillin,
ciprofloxacin,
levofloxacin, aztreonam, ceftazidime,
gentamicin, imipenem, andmeropenem
were employed. All drugs have dissimilar
resistant as well as sensitive patterns in
accordance with their zone of inhibition.
The antimicrobial susceptibility profile of
P. aeruginosaisolated from non-critical
areas compared to these drugs being
described in Table 4. The current research
demonstrates the fraction of
P.
aeruginosabeing isolated from non-critical
areas were mostly resistant to these drugs
meropenem 54.8 %, levofloxacin 43.9 %,
Gentamicin 36.5 %, ceftazidime 30.4 %
(Figure 1), and 97.5 % sensitivity was
observed against imipenem followed by
piperacillin 95.1 %.

Table 4: Antimicrobial susceptibility profile of isolated P. aeruginosaas of non-critical regions (N=82).
Antibiotics

Resistant
N ( %)

Sensitive
N ( %)

Piperacillin
Ceftazidime
Ciprofloxacin
Levofloxacin
Gentamicin
Imipenum
Meropenum
Aztreonum

18 (21.9 %)
25 (30.4 %)
29 (35.3 %)
36 (43.9 %)
30 (36.5 %)
10 (12.19 %)
45 (54.8 %)
16 (19.5 %)

78 (95.1 %)
72 (87.8 %)
65 (79.2 %)
52 (63.4 %)
77 (93.9 %)
80 (97.5 %)
42 (51.2 %)
69 (84.1 %)
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80
60
40

Resistance

20

Sensitive

0

Antibiotics

Figure 1: Percentage of antimicrobial resistance of P. aeruginosaisolated from non-critical areas.
Table 5: Antimicrobial sensitivity profile of isolated P. aeruginosa from Critical areas (N=28)
Antibiotics

Resistant
N (%)

Sensitive
N (%)

Piperacillin
Ceftazidime
Ciprofloxacin
Levofloxacin
Gentamicin
Imipenum
Meropenum
Aztreonum

28 (100 %)
28 (100 %)
14 (50 %)
11 (39.2 %)
28 (100 %)
17 (60.7 %)
28 (100 %)
17 (60.7 %)

0 (0 %)
0 (0 %)
6 (21.4 %)
8 (28.5 %)
0 (0 %)
4 (14.2 %)
0 (0 %)
5 (17.8 %)

120
100
%age

80
60
40

Resistance

20

Sensitive

0

Antibiotics

Figure 2: Percentage of antimicrobial resistance of P. aeruginosaisolated from critical areas.
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In critical units, all P. aeruginosa
isolates were reported to be multi drug
resistant. Multi drug resistant (MDR)
means that microorganisms are resistant to
penicillin, cephalosporins, quinolones and
aminoglycosides (Dash et al., 2014). The
antimicrobial sensitivity profile of this
MDR, P. aeruginosais is represented in
Table 5. This isolated P. aeruginosafrom
critical areas was most resistant to
piperacillin 100 %, ceftazidime 100 %,
gentamicin 100 %, and meropenem 100 %
as shown in Figure 2.
DISCUSSION
P. aeruginosais a ubiquitous
Gram-negative rod which is linked to
numerous
infections
for
instance
pneumonia, bacteremia, urinary tract, skin
infection, etc. P. aeruginosaparticularly
affects immune-compromised patients
(Juan et al., 2010). This species is
considered as a major opportunistic human
pathogen, which is accountable for
universal nosocomial diseases with
escalating medical along with veterinary
consequences (P.D et al., 2009). Due to the
emergence of MDR clinical isolates, P.
aeruginosais considered a global health
problem (M.E et al., 2015). This scenario
leaves the clinicians with few therapeutic
antibacterial drugs for the cure of
contagious diseases (Farooq et al., 2019).
In the current research, a 29.49 %
frequency of P. aeruginosawas observed,
which was like findings of India as 32.1 %
(Rajat et al., 2012). On contrary, the low
prevalence of 2.1 % was observed by a
previous study done in Nigeria (OKon et
al., 2009). The varied prevalence of P.
aeruginosamay be due to the different
places and the way of receiving clinical
samples
for
examination,
studied
population, geographical locations, and
types of hospitals. In our study, higher
isolation of P. aeruginosawas observed in
pus samples (30 %) from non-critical
areas. These results were supported by
previous studies where pus/wounds

specimens were the frequent cause (Saeed
et al., 2018).Most of the patients have
complications on wound locations and are
very effortless intentions for nosocomial
pathogens. Thus, this is the basic fact to
justify the existence of the maximum
number of isolates in pus samples. Poor
hygiene
and
inadequate
antiseptic
measures in the wards may be contributed
to acquiring the resistant strains (Farooq et
al., 2019).
In our observation, the highest
distribution of P. aeruginosawas found in
the surgery ward (46.2 %) among noncritical areas. These results have coincided
with the previous study where 29.6 % of
P. aeruginosawas isolated from postoperative patients (Ranjan et al., 2010). On
the other hand, Kumari has recorded a
lower isolation rate of P. aeruginosafrom
the surgical ward (Kumari et al., 2019).
According to research, the highest isolates
of P. aeruginosaas of MICU among
critical areas, whereas lower isolation 42.9
% was found by Saeed (Saeed et al.,
2018).
According
to
antimicrobial
susceptibility profile of P. aeruginosafrom
non-critical units, it showed resistance to
meropenem (54.8 %) followed by
levofloxacin (43.9 %) and ciprofloxacin
(35.3 %). Bayani reported the same results
as in our study (Bayani et al., 2013;
Rytekar et al., 2017). Minimum resistance
was found against imipenem (12.19 %).
This result relates with the investigation
made by Rakhee (Rakhee et al., 2014).
However, isolates of P. aeruginosa from
critical areas were opposed to various
groups of antibiotics. Currently, available
drugs in our research for MDR P.
aeruginosacontain
Fluoroquinolones
(ciprofloxacin,
levofloxacin),
Cephalosporins
(ceftazidime),
Aminoglycosides (gentamicin), Antipseudomonalpenicillins
(piperacillin),
Monobactum
(aztreonam),
and
Carbapenems (Imepenum, meropenem).
Like other studies, high resistance was
81
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demonstrated in our research against all
beta-lactam antibiotics (Savas et al., 2005).
Concerning antibiotic sensitivity,
the maximum resistance was found against
piperacillin (100 %), ceftazidime (100 %),
gentamicin (100 %), and meropenem (100
%) while these isolates expressed the
highest susceptibility to levofloxacin (28.5
%). However, the highest resistance rate
against piperacillin, ceftazidime, and
meropenem was reported in previous
studies respectively (Asghar and Faidah,
2009; Al-agamy et al., 2011; Asghar,
2012). Previous studies reported the
highest resistance against piperacillin (100
%), gentamicin (98 %) (Ameen et al.,
2015). Thus, the differences in the
resistance rate may be due to prescribing
activities of all hospitals as well as the
accumulative
stress
of
particular
antimicrobial agents (Sarwat et al., 2015).
From the above findings, we have
analyzed that the resistance rate is still
higher in critically ill patients than the
non-critical
patients.
This
study
emphasizes the imperative require for
balanced apply of antibiotics and severe
constancy to thought of reserve
prescription, to reduce the misuse of all
currently accessible antimicrobials (Javiya
et al., 2008).
CONCLUSION
The present study uncovered the
resurgence of P. aeruginosain contrast to
different antibiotics. It plays a great role in
apprehending the manifestation of multi
drug resistant isolates in intensive care
units been escalating at a frightening
speed. Therefore, consistent surveillance
and appropriate measures are required to
reduce HAIs and antimicrobial resistance.
Regular monitoring of Pseudomonas
sources in different wards and proper
management of wards disinfection and
instrumental sterilization along with hand
hygiene is mandatory to reduce the
Hospital
acquired
infections
and
resistance.
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